Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control
- PMID: 33602078
- DOI: 10.2174/1871526521666210218201113
Natural Derived Nasal Spray; A Proposed Approach for COVID-19 Disease Control
Abstract
Considering the importance of COVID-19 disease pandemic, emerged by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in line with other studies to find appropriate prevention or treatment methods for this virus infection, our study objective was proposing the use of natural derived ingredients as an approach for COVID-19 disease control. Here we reviewed previous studies on natural derived nasal sprays andfound that some known natural derived ingredients have antiviral properties, so their topical use as a nasalspray is effective in reducing the symptoms of respiratory infections. Moreover, such nasal sprays also have thepotential of decreasing viral load, including titer of coronaviruses, in the nasal cavity. It seems that the use ofcarrageenan or other herbal ingredients in the nasal spray may block the SARS-CoV-2 virus from entering thelung cells of an affected person and can also prevent virus transmission to other susceptible persons. Further,noticing what we know about the novel 2019 coronavirus so far, we suggested carrageenan that has an unspecific physical antiviral activity and some other natural derived ingredients, as a choice in coping with SARS-CoV-2 virus infection.
Keywords: Acute respiratory infections; COVID-19; SARS-CoV-2; carrageenan; nasal sprays; natural derived ingredients.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures.Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L750-L756. doi: 10.1152/ajplung.00552.2020. Epub 2021 Feb 9. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 33561380 Free PMC article.
-
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.Viruses. 2021 Aug 20;13(8):1656. doi: 10.3390/v13081656. Viruses. 2021. PMID: 34452519 Free PMC article.
-
Virucidal activity of nasal sprays against severe acute respiratory syndrome coronavirus-2.J Hosp Infect. 2022 Feb;120:9-13. doi: 10.1016/j.jhin.2021.10.019. Epub 2021 Nov 6. J Hosp Infect. 2022. PMID: 34752803 Free PMC article.
-
Nitric Oxide and its Derivatives Containing Nasal Spray and Inhalation Therapy for the Treatment of COVID-19.Curr Pharm Des. 2022;28(46):3658-3670. doi: 10.2174/1381612829666221024124848. Curr Pharm Des. 2022. PMID: 36284382 Review.
-
COVID-19: Topical agents and therapeutic prevention of nasal viral acquisition.Dermatol Ther. 2021 Jan;34(1):e14454. doi: 10.1111/dth.14454. Epub 2020 Nov 10. Dermatol Ther. 2021. PMID: 33107144 Review.
Cited by
-
The Mucoadhesive Nanoparticle-Based Delivery System in the Development of Mucosal Vaccines.Int J Nanomedicine. 2022 Sep 28;17:4579-4598. doi: 10.2147/IJN.S359118. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36199476 Free PMC article. Review.
-
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules.Int J Mol Sci. 2022 May 29;23(11):6083. doi: 10.3390/ijms23116083. Int J Mol Sci. 2022. PMID: 35682761 Free PMC article.
-
A Supine Position and Dual-Dose Applications Enhance Spray Dosing to the Posterior Nose: Paving the Way for Mucosal Immunization.Pharmaceutics. 2023 Jan 20;15(2):359. doi: 10.3390/pharmaceutics15020359. Pharmaceutics. 2023. PMID: 36839681 Free PMC article.
-
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges.Hum Vaccin Immunother. 2022 Nov 30;18(5):2045853. doi: 10.1080/21645515.2022.2045853. Epub 2022 Mar 8. Hum Vaccin Immunother. 2022. PMID: 35258416 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous